CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)	Preferred Stock Series A	Preferred Stock Series B	Preferred Stock Series C	Preferred Stock Series D	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance, beginning at Dec. 31, 2016					$ 420	$ 1,902,161	$ (2,799,193)	$ (896,612)
Balance, beginning (shares) at Dec. 31, 2016	37,530	71			336,957
Pre-merger issuances of shares
Pre-merger issuances of shares (Shares)	42,470	(56)	12		94,756
Shares repurchased from shareholder								0
Pre-merger conversion of shares
Pre-merger conversion of shares (Shares)					220,083
Issuance of employee and director stock options						6,397		6,397
Issuance of employee and director stock options (shares)
Warrants issued with convertible promissory note						9,082		9,082
Warrants issued with convertible promissory note (Shares)
Share compensation period costs						22,192		22,192
Net loss							(797,215)	(797,215)
Balance, ending at Dec. 31, 2017					$ 420	1,939,832	(3,596,408)	(1,656,156)
Balance, ending (shares) at Dec. 31, 2017	80,000	14	12		651,796
Pre-merger issuances and conversions of shares
Pre-merger issuances and conversions of shares (shares)	(80,000)	(6)	(12)		3,548,204
Sale of Series C preferred stock						250,000		250,000
Sale of Series C preferred stock (Shares)			250
Founder stock returned to company					$ (75)	75
Founder stock returned to company (Shares)					(75,000)
Shares repurchased from shareholder					$ (140)	(210,503)		(210,643)
Shares repurchased from shareholder (Shares)					(139,567)
Conversion of Series B and C preferred stock			$ (2)		$ 1,616	(1,614)
Conversion of Series B and C preferred stock (Shares)		(8)	(2,467)		1,616,470
Exercise of options					$ 56	(56)
Exercise of options (Shares)					55,801
Issuance of employee and director stock options								0
Issuance of common stock for consulting services					$ 185	400,415		400,600
Issuance of common stock for consulting services (Shares)					185,000
AgEagle debt conversion into common stock					$ 788	1,503,015		1,503,803
AgEagle debt conversion into common stock (Shares)					787,891
AgEagle shareholder common stock conversion to Enerjex common shares			$ 2		$ 6,537	(6,539)
AgEagle shareholder common stock conversion to Enerjex common shares (Shares)			2,056		2,757,063
Acquisition of Agribotix					$ 1,275	2,998,725		3,000,000
Acquisition of Agribotix (Shares)					1,275,000
Issuance of common and preferred stock for Enerjex shareholders upon merger					$ 1,887	(762,662)		(760,775)
Issuance of common and preferred stock for Enerjex shareholders upon merger (Share)	0	0	197	0	1,886,736
Issuance of Series C common stock in connection with merger, net of fees	$ 0	$ 0	$ 5	$ 0	$ 0	3,979,995		3,980,000
Issuance of Series C common stock in connection with merger, net of fees (Shares)	0	0	4,626	0	0
Warrants issued with convertible promissory note								0
Issuance of Series D preferred stock and warrants for cash				$ 2		1,969,998		1,970,000
Issuance of Series D preferred stock and warrants for cash (Shares)				2,000
Share compensation period costs						110,593		110,593
Net loss							(2,079,683)	(2,079,683)
Balance, ending at Dec. 31, 2018			$ 5	$ 2	$ 12,549	$ 12,171,274	$ (5,676,091)	$ 6,507,739
Balance, ending (shares) at Dec. 31, 2018			4,662	2,000	12,549,394